Jump to contentJump to search
Symbolbild Neurone im Raum

GOPC: ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.
Sievers et al., Acta Neuropathol. [in press]

Philipp Sievers, Damian Stichel, Martin Sill, Daniel Schrimpf, Dominik Sturm, Florian Selt, Jonas Ecker, Daniel Kazdal, Evelina Miele, Mariëtte E G Kranendonk, Bastiaan B J Tops, Patricia Kohlhof-Meinecke, Rudi Beschorner, Christof M Kramm, Martin Hasselblatt, Guido Reifenberger, David Capper, Pieter Wesseling, Albrecht Stenzinger, Till Milde, Andrey Korshunov, Olaf Witt, Stefan M Pfister, Wolfgang Wick, Andreas von Deimling, David T W Jones, Felix Sahm.

GOPC: ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types.

Acta Neuropathol. 2021 Sep 18. doi: 10.1007/s00401-021-02369-1. [Epub ahead of print] PubMed ID: 34536122

 

Further Information:

PubMed

Guido Reifenberger

Kategorie/n: NND-Publikationen
Responsible for the content: